Broadly Neutralizing Antibodies for HIV Prevention, Therapy and Cure
Marina Caskey, MD
Associate Professor of Clinical Investigation
The Rockefeller University, New York, NY
Videos of live meetings of PRN in NYC are owned and published by Physicians’ Research Network, Inc.
Copyright © 2019. All rights reserved.
Marina Caskey is an Associate Professor of Clinical Investigation at The Rockefeller University and an attending physician in infectious diseases at New York Presbyterian-Weill Cornell Medical Center. Her research in broadly neutralizing antibodies have revitalized this area of HIV research, which are now considered one of the most promising strategies to achieve HIV remission, as well as potential alternatives to antiretrovirals for both therapy and prevention of HIV disease.
At the completion of this educational session, learners will:
- Better understand the challenges to HIV eradication.
- Be aware of current immunologic approaches to treat, eradicate or prevent HIV infection.
- Know the results of recent clinical trials of HIV immunotherapy and implications for future studies.
This PRN CME activity is funded in part by unrestricted educational grants from:
Gilead Sciences; Janssen Therapeutics, a division of Janssen Products, LP; and Merck & Co.
